Recalled ranitidine drugs had excessive amounts of NDMA carcinogen


KUALA LUMPUR: Ten recalled drugs containing the active ingredient ranitidine that treats stomach ulcers have been confirmed to contain the impurity N-Nitrosodimethylamine (NDMA) above the permitted level, said the Health Ministry.

Health director-general Datuk Dr Noor Hisham Abdullah said that the recall was based on evaluations and laboratory tests carried out by the ministry and companies holding the drug registrations, as well as information from international regulatory bodies.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

 Ranitidine , NDMA , Health Ministry , Carcinogen

   

Next In Nation

Civil Defence Force Melaka prepares for Northeast Monsoon with boat handling exercise
Public urged to use public transport for two years of Madani govt programme at KLCC
Cops to work with Myanmar and int'l agencies to verify claims of Jho Low's whereabouts
Sarawak to host 15th World Congress on Design and Health in 2026
Perikatan willing to resume MOU talks if terms are fair, says Hamzah
70yo man arrested for murder in Sabah
Rural and Regional Ministry introduces smart village concept to empower rural communities
Couple and associate charged with trafficking 51.9kg of meth in Perak
Trainees urged to uphold integrity and avoid corruption, says IGP
UPNM cadet claims trial to causing hurt to junior using spiked boot in latest bullying case

Others Also Read